Vontobel Holding’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.8M Buy
346,381
+57,691
+20% +$10.9M 0.21% 108
2026
Q1
$56.1M Buy
288,690
+284,494
+6,780% +$54.9M 0.19% 109
2025
Q4
$771K Sell
4,196
-767
-15% -$135K ﹤0.01% 835
2025
Q3
$761K Hold
4,963
﹤0.01% 809
2025
Q2
$694K Buy
4,963
+17
+0.3% +$2.38K ﹤0.01% 799
2025
Q1
$727K Buy
+4,946
New +$716K ﹤0.01% 679
2023
Q4
Sell
-4,220
Closed -$572K 1112
2023
Q3
$572K Buy
4,220
+119
+3% +$16.3K 0.01% 727
2023
Q2
$587K Buy
4,101
+96
+2% +$14.1K 0.01% 751
2023
Q1
$556K Buy
4,005
+2,452
+158% +$330K 0.01% 755
2022
Q4
$210K Sell
1,553
-678
-30% -$85K ﹤0.01% 985
2022
Q3
$245K Buy
2,231
+678
+44% +$86K ﹤0.01% 901
2022
Q2
$208K Buy
+1,553
New +$204K ﹤0.01% 932

Other funds holding AZN

Vontobel Holding's AZN Position: Q2 2026 in Review

Vontobel Holding increased its AstraZeneca (AZN) stake by 20% in Q2 2026, buying an estimated $10.9M and bringing the position to 346,381 shares worth $64.8M. The position accounts for 0.21% of the portfolio, ranked #108.

Vontobel Holding first reported a position in AZN in Q2 2022 and has held it in 12 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Vontobel Holding held 346,381 shares of AstraZeneca worth $64.8M as of Q2 2026.
  • Vontobel Holding bought 57,691 AstraZeneca shares in Q2 2026, an estimated $10.9M.
  • AstraZeneca made up 0.21% of Vontobel Holding's portfolio in Q2 2026, its #108 holding.
  • Vontobel Holding first reported a position in AstraZeneca in Q2 2022 and has held it in 12 quarters since.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.